IN2012DN02675A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02675A
IN2012DN02675A IN2675DEN2012A IN2012DN02675A IN 2012DN02675 A IN2012DN02675 A IN 2012DN02675A IN 2675DEN2012 A IN2675DEN2012 A IN 2675DEN2012A IN 2012DN02675 A IN2012DN02675 A IN 2012DN02675A
Authority
IN
India
Prior art keywords
met
cess
indazol
dicyano
pro
Prior art date
Application number
Inventor
Michels Martin
Follmann Markus
Vakalopoulos Alexandros
Zimmermann Katja
Teusch Nicole
Lobell Mario
Bierer Donald
Engel Karen
Kissel Maria
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of IN2012DN02675A publication Critical patent/IN2012DN02675A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The present invention relates to novel fluoro-substituted 3,5-dicyano-4-(1H-indazol-5-yl)-2,6-di-methyl-l,4-dihydropyridine derivatives having protein tyrosine kinase inhibitory activity, to a pro¬cess for the manufacture thereof and to the use thereof for the treatment of c-Met-mediated diseases or c-Met-mediated conditions, particularly cancer and other proliferative disorders.
IN2675DEN2012 2009-10-06 2010-10-01 IN2012DN02675A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09172304 2009-10-06
PCT/EP2010/064648 WO2011042368A1 (en) 2009-10-06 2010-10-01 Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof

Publications (1)

Publication Number Publication Date
IN2012DN02675A true IN2012DN02675A (en) 2015-09-04

Family

ID=43357944

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2675DEN2012 IN2012DN02675A (en) 2009-10-06 2010-10-01

Country Status (27)

Country Link
US (1) US9422263B2 (en)
EP (1) EP2485726B1 (en)
JP (1) JP5753175B2 (en)
KR (1) KR20120091005A (en)
CN (1) CN102573838B (en)
AR (1) AR078486A1 (en)
AU (1) AU2010305550A1 (en)
BR (1) BR112012006842A2 (en)
CA (1) CA2773676C (en)
CL (1) CL2012000753A1 (en)
CR (1) CR20120150A (en)
CU (1) CU20120051A7 (en)
DO (1) DOP2012000085A (en)
EC (1) ECSP12011748A (en)
ES (1) ES2458117T3 (en)
IL (1) IL218415A0 (en)
IN (1) IN2012DN02675A (en)
MX (1) MX2012003603A (en)
NZ (1) NZ599006A (en)
PE (1) PE20121392A1 (en)
PH (1) PH12012500640A1 (en)
RU (1) RU2012111695A (en)
SG (1) SG178990A1 (en)
TW (1) TW201124396A (en)
UY (1) UY32922A (en)
WO (1) WO2011042368A1 (en)
ZA (1) ZA201201524B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0650179Y2 (en) 1989-06-01 1994-12-21 株式会社プラコー Die head for blow molding machine
JPH0756186Y2 (en) 1989-07-24 1995-12-25 株式会社日本製鋼所 Parison extrusion equipment
JP2781376B2 (en) 1996-06-17 1998-07-30 エクセル株式会社 Hollow molded products
DE102009056886A1 (en) * 2009-12-03 2011-06-09 Bayer Schering Pharma Aktiengesellschaft cMet inhibitors for the treatment of endometriosis
AR118043A1 (en) 2019-02-11 2021-09-15 Merck Patent Gmbh INDAZOLIL-ISOXAZOLE DERIVATIVES AS INHIBITORS OF c-KIT KINASE

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635977A (en) 1969-11-03 1972-01-18 American Cyanamid Co Certain 6-trifluoromethylcytosines and thiocytosines their synthesis and their use in the synthesis of uracisls and thiouracil
DK0379917T3 (en) 1989-01-26 1995-12-11 Bayer Ag Optically active (meth) acrylic acid propellants, their preparation, their polymerization for optically active polymers and their use
DE19546136A1 (en) 1995-12-11 1997-06-12 Bayer Ag Chiral stationary phases for the chromatographic separation of optical isomers
CN1656079A (en) 2002-05-31 2005-08-17 卫材株式会社 Pyrazole compound and pharmaceutical composition containing same
JP2007526324A (en) 2004-03-02 2007-09-13 スミスクライン・ビーチャム・コーポレイション Inhibitors with AKT activity
EP1722792A1 (en) 2004-03-03 2006-11-22 Boehringer Ingelheim International GmbH Selected cgrp-antagonists, method for the production and use thereof as medicaments
US20090298872A1 (en) 2004-12-13 2009-12-03 Irm Llc Compounds and compositions as modulators of steroidal receptors and calcium channel activities
EP1858325A4 (en) 2005-01-07 2010-06-30 Roskamp Res Llc Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
CN101193637A (en) * 2005-01-19 2008-06-04 默克公司 Fluorinated aminoalkyl-4-oxo-3, 4-dihydropyrido [3, 4-d ] pyrimidine compounds as mitotic kinesin inhibitors
CA2672167C (en) * 2006-12-14 2016-01-26 Bayer Schering Pharma Aktiengesellschaft Dihydropyridine derivatives useful as protein kinase inhibitors

Also Published As

Publication number Publication date
CN102573838A (en) 2012-07-11
CU20120051A7 (en) 2012-06-29
PE20121392A1 (en) 2012-10-14
CR20120150A (en) 2012-08-03
CL2012000753A1 (en) 2012-09-14
CN102573838B (en) 2014-09-24
AU2010305550A1 (en) 2012-03-29
CA2773676A1 (en) 2011-04-14
EP2485726A1 (en) 2012-08-15
RU2012111695A (en) 2013-10-10
HK1172835A1 (en) 2013-05-03
ZA201201524B (en) 2013-05-29
TW201124396A (en) 2011-07-16
MX2012003603A (en) 2012-04-20
WO2011042368A1 (en) 2011-04-14
KR20120091005A (en) 2012-08-17
SG178990A1 (en) 2012-04-27
NZ599006A (en) 2013-11-29
CA2773676C (en) 2017-07-04
US20120264785A1 (en) 2012-10-18
JP2013506699A (en) 2013-02-28
DOP2012000085A (en) 2012-07-15
US9422263B2 (en) 2016-08-23
JP5753175B2 (en) 2015-07-22
ES2458117T3 (en) 2014-04-30
ECSP12011748A (en) 2012-05-30
IL218415A0 (en) 2012-04-30
UY32922A (en) 2011-04-29
BR112012006842A2 (en) 2016-06-07
EP2485726B1 (en) 2014-03-12
PH12012500640A1 (en) 2012-11-12
AR078486A1 (en) 2011-11-09

Similar Documents

Publication Publication Date Title
MY148851A (en) Dihydropyridine derivatives as useful as protein kinase inhibitors
WO2007106236A3 (en) Pyrrolo-pyridine kinase modulators
TN2012000081A1 (en) Compounds and compositions as protein kinase inhibitors
GEP20146101B (en) Pyridine and pyrazine derivatives as protein kinase modulators
WO2010083207A3 (en) Protein kinase c inhibitors and uses thereof
MX2009011951A (en) Compounds and compositions as c-kit and pdgfr kinase inhibitors.
WO2011014795A3 (en) Compounds and compositions as syk kinase inhibitors
WO2009097287A9 (en) Compounds and compositions as kinase inhibitors
MX2009007944A (en) Compounds and compositions as kinase inhibitors.
MX2009004716A (en) Compounds and compositions as protein kinase inhibitors.
MX2009012623A (en) Heterocyclic kinase modulators.
MXPA05010711A (en) Novel compounds and compositions as protein kinase inhibitors.
EA201270480A1 (en) NEW CONNECTIONS
MX2009011950A (en) Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors.
CL2015000096A1 (en) Compounds derived from 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta [a] naphthalenes, phosphodiestearase 2 and / or 10 inhibitors; pharmaceutical composition; and its use for prevention or treatment of diseases of the nervous system, such as cognitive deficiency, dementia, anxiety disorders, enf. from Alzheimer, enf. from parkinson, others
MX2009013353A (en) Telomerase activating compounds and methods of use thereof.
MX2009011952A (en) Compounds and compositions as c-kit and pdgfr kinase inhibitors.
MX2009006170A (en) Compounds and compositions as kinase inhibitors.
ATE523510T1 (en) SUBSTITUTED 4-ARYL-1,4-DIHYDRO-1,6-NAPHTHHYRIDINES AND THEIR USE
IN2012DN02471A (en)
CU20110215A7 (en) SUBSTITUTED PIPERIDINS
PH12012500640A1 (en) Fluoro-substituted 3,5 - dicyano -4- (1h-indazol -5- yl) -2,6- dimethyl -1,4- dihydropyridine derivatives and methods of use thereof
ATE540042T1 (en) ANNATED 4-(INDAZOLYL)-1,4-DIHYDROPYRIDINE DERIVATIVES AS C-MET MEDIATORS
WO2010083311A3 (en) Compositions and methods of use
MX371027B (en) Novel benzopyran kinase modulators.